1091P Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant checkpoint inhibitor and subsequent surgical resection in patients with BRAF V600-mutated stage III/IV melanoma
| Autor: | Weber, J.S., Haque, W., Markovic, S.N., Salama, A.K.S., Mehmi, I., Sullivan, R.J., Najjar, Y.G., van Akkooi, A.C.J., Menzies, A.M., Long, G.V., Taylor, A.M., Haanen, J.B.A.G., Zijlker, L., Davis, K., Karanth, S., Shah, R., Connolly, L., Norton, D. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S657-S658 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|